See What HealthDay Can Do For You
Contact Us

Generic Crestor Approved by FDA

First generic version of Crestor (rosuvastatin calcium)

fda logo

FRIDAY, April 29, 2016 (HealthDay News) -- The first generic version of Crestor (rosuvastatin calcium) tablets was approved Friday by the U.S. Food and Drug Administration.

Watson Pharmaceuticals Inc. of New Jersey received approval to market generic rosuvastatin calcium in multiple strengths for certain uses.

These uses include: in combination with diet for the treatment of hypertriglyceridemia in adults, in combination with diet for treatment of patients with primary dysbetalipoproteinemia (type III hyperlipoproteinemia), and either alone or in combination with other cholesterol treatment(s) for adult patients with homozygous familial hypercholesterolemia.

"The FDA is working hard to get first-time generic drugs approved as quickly as possible so patients can have increased access to needed treatments," Kathleen Uhl, M.D., director of the Office of Generic Drugs in the FDA's Center for Drug Evaluation and Research, said in a statement. "The FDA requires that generic drugs meet rigorous scientific and quality standards."

More Information

Physician's Briefing

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.